Investigation Into the Pathophysiology and Treatment of Varicose Veins

NCT06192472 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Varicose Veins

Interventions

PROCEDURE: Chemical sclerotherapy
DRUG: 1% Sodium Tetradecyl Sulphate
DRUG: 3% Sodium Tetradecyl Sulphate
DRUG: 0.5% Polidocanol
DRUG: 3% Polidcanol

Sponsor

University of Surrey

Collaborators

[object Object]